About romiplosti m
Thrombopoietin receptor agonist
Used for
- Raises platelet counts in adults with immune thrombocytopenia when other treatments have not worked well.
- Treats immune thrombocytopenia in children aged one year and older after other treatments have not worked well.
- Treats low platelet counts in adults with aplastic anaemia in certain settings.
Usual adult dose
Immune thrombocytopenia: 1 microgram/kg under the skin weekly, adjusted to platelet counts; maximum 10 micrograms/kg weekly. Aplastic anaemia dosing differs by treatment setting.
Usual dose in children
Age one year and older: 1 microgram/kg under the skin weekly, adjusted to platelet counts; maximum 10 micrograms/kg weekly.
Common side effects
- Headache
- Joint or muscle pain
- Dizziness
- Blood clots or increased bone marrow reticulin
Important warnings
- Platelet counts can rise too high, increasing clot risk.
- Stopping treatment can cause platelet counts to fall and bleeding risk to rise.
- Blood counts and liver function require monitoring.
- Use the lowest dose needed to reduce bleeding risk.
Pregnancy
Human pregnancy information is limited; use only when benefits outweigh potential risks.
Breastfeeding
It is unknown whether romiplostim passes into breast milk; breastfeeding decisions require clinical assessment.
Interactions
- No specific drug interactions are well established.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.